Poisonous pill
14 February 2018

The struggling U.S. vitamin vendor is selling a 40 pct stake to Harbin Pharmaceutical. That should help open the door to a big market. The price is steep, though. Convertible shares come with nearly half the board, giving GNC’s partner the muscle to block any future rescue deals.